Skip to main content
Erschienen in: European Journal of Pediatrics 10/2006

01.10.2006 | Original Paper

Characteristics of HIV-infected children recently diagnosed in Paris, France

verfasst von: Eugenia Macassa, Marianne Burgard, Florence Veber, Capucine Picard, Bénédicte Neven, Nizar Malhaoui, Christine Rouzioux, Stéphane Blanche

Erschienen in: European Journal of Pediatrics | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Pediatric HIV-1 infections are still being diagnosed in France, despite the efficacy of prophylactic treatment to prevent mother-to-child transmission. To describe the characteristics and mode of infection of these children, we retrospectively analysed data of 59 children diagnosed with the HIV-1 infection between January 2000 and June 2005 in a Parisian university hospital. Twenty of these children had been born in France, and none had received appropriate prophylaxis (insufficient, not taken or given too late). Six received no preventive treatment due to failures in screening: three mothers were HIV-seronegative at the start of pregnancy and no test was carried out for the other three. At diagnosis, four had a severe immune deficiency (CD4 cells <15%). The 39 children born abroad were diagnosed at a median age of 3 years (range: 3 months–16 years), sometimes several years after their arrival in France. The clinical, virological and immunological status of these children was poorer than that of the children born in France: 18 had less than 15% CD4 cells. In contrast, the response to treatment of the children born in France was not as good as that of the children born abroad. The HIV-1 screening and prevention programme for pregnant women could be improved. Some children infected following the failure of prevention are at high risk of subsequent treatment failure. HIV-1 infection should be taken into consideration in children born in countries with a high prevalence of HIV, even if they have been living in France for several years and present no symptoms.
Literatur
1.
Zurück zum Zitat Abrams EJ (2004) Prevention of mother-to-child transmission of HIV-successes, controversies and critical questions. AIDS Rev 6:131–143PubMed Abrams EJ (2004) Prevention of mother-to-child transmission of HIV-successes, controversies and critical questions. AIDS Rev 6:131–143PubMed
2.
Zurück zum Zitat Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C (2005) Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 40:96–101PubMedCrossRef Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C (2005) Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 40:96–101PubMedCrossRef
3.
Zurück zum Zitat Chou R, Smits AK, Huffman LH, Fu R, Korthuis PT, US Preventive Services Task Force (2005) Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 143:38–54PubMed Chou R, Smits AK, Huffman LH, Fu R, Korthuis PT, US Preventive Services Task Force (2005) Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 143:38–54PubMed
4.
Zurück zum Zitat Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al (2002) Women and Infant’s Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29:484–94PubMed Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al (2002) Women and Infant’s Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29:484–94PubMed
5.
Zurück zum Zitat del Rio C, U.S. Preventive Services Task Force (2005) New USPSTF guidelines on HIV screening. AIDS Clin Care 17:74PubMed del Rio C, U.S. Preventive Services Task Force (2005) New USPSTF guidelines on HIV screening. AIDS Clin Care 17:74PubMed
6.
Zurück zum Zitat European Collaborative Study (2003) Pregnancy-related changes in the longer-term management of HIV-infected women in Europe. Eur J Obstet Gynecol Reprod Biol 111:3–8CrossRef European Collaborative Study (2003) Pregnancy-related changes in the longer-term management of HIV-infected women in Europe. Eur J Obstet Gynecol Reprod Biol 111:3–8CrossRef
7.
Zurück zum Zitat European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458–465CrossRef European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458–465CrossRef
8.
Zurück zum Zitat Foster C, Lyall EG (2005) Children with HIV: improved mortality and morbidity with combination antiretroviral therapy. Curr Opin Infect Dis 18:253–259PubMedCrossRef Foster C, Lyall EG (2005) Children with HIV: improved mortality and morbidity with combination antiretroviral therapy. Curr Opin Infect Dis 18:253–259PubMedCrossRef
9.
Zurück zum Zitat Hawkins D, Blott M, Clayden P, de Ruiter A, Foster G, Gilling-Smith C, et al (2005) BHIVA Guidelines Writing Committee. Guidelines for the management of HIV infection in 12 pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 6[Suppl 2]:107–148PubMedCrossRef Hawkins D, Blott M, Clayden P, de Ruiter A, Foster G, Gilling-Smith C, et al (2005) BHIVA Guidelines Writing Committee. Guidelines for the management of HIV infection in 12 pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 6[Suppl 2]:107–148PubMedCrossRef
10.
Zurück zum Zitat Jenista JA (2005) Special topics in international adoption. Pediatr Clin North Am 52:1479–1494PubMedCrossRef Jenista JA (2005) Special topics in international adoption. Pediatr Clin North Am 52:1479–1494PubMedCrossRef
11.
Zurück zum Zitat Kelly KA, Harrison CH (2004) Universal prenatal HIV screening: patient attitudes and perceptions. Women Health 40:41–57PubMedCrossRef Kelly KA, Harrison CH (2004) Universal prenatal HIV screening: patient attitudes and perceptions. Women Health 40:41–57PubMedCrossRef
12.
Zurück zum Zitat King SM; American Academy of Pediatrics Committee on Pediatric AIDS; American Academy of Pediatrics Infectious Diseases and Immunization Committee (2004) Evaluation and treatment of the human immunodeficiency virus-1-exposed infant. Pediatrics 114:497–505PubMedCrossRef King SM; American Academy of Pediatrics Committee on Pediatric AIDS; American Academy of Pediatrics Infectious Diseases and Immunization Committee (2004) Evaluation and treatment of the human immunodeficiency virus-1-exposed infant. Pediatrics 114:497–505PubMedCrossRef
13.
Zurück zum Zitat Loutfy MR, Walmsley SL (2004) Treatment of HIV infection in pregnant women: antiretroviral management options. Drugs 64:471–488PubMedCrossRef Loutfy MR, Walmsley SL (2004) Treatment of HIV infection in pregnant women: antiretroviral management options. Drugs 64:471–488PubMedCrossRef
14.
Zurück zum Zitat Mayaux MJ, Teglas JP, Blanche S, French Pediatric HIV Infection Study Group (2003) Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort. J Acquir Immune Defic Syndr 34:338–343PubMedCrossRef Mayaux MJ, Teglas JP, Blanche S, French Pediatric HIV Infection Study Group (2003) Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort. J Acquir Immune Defic Syndr 34:338–343PubMedCrossRef
15.
Zurück zum Zitat Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J (2005) Protease inhibitor use in 233 pregnancies. J Acquir Immune Defic Syndr 40:30–33PubMedCrossRef Morris AB, Dobles AR, Cu-Uvin S, Zorrilla C, Anderson J, Harwell JI, Keller J, Garb J (2005) Protease inhibitor use in 233 pregnancies. J Acquir Immune Defic Syndr 40:30–33PubMedCrossRef
16.
Zurück zum Zitat Murray TS, Groth ME, Weitzman C, Cappello M (2005) Epidemiology and management of infectious diseases in international adoptees. Clin Microbiol Rev 18:510–520PubMedCrossRef Murray TS, Groth ME, Weitzman C, Cappello M (2005) Epidemiology and management of infectious diseases in international adoptees. Clin Microbiol Rev 18:510–520PubMedCrossRef
17.
Zurück zum Zitat Neely M, Kovacs A (2004) Management of antiretroviral therapy in neonates, children, and adolescents. Curr HIV/AIDS Rep 1:97–104PubMedCrossRef Neely M, Kovacs A (2004) Management of antiretroviral therapy in neonates, children, and adolescents. Curr HIV/AIDS Rep 1:97–104PubMedCrossRef
18.
Zurück zum Zitat Pearlman DN, Averbach AR, Zierler S, Cranston K (2005) Disparities in prenatal HIV testing: evidence for improving implementation of CDC screening guidelines. J Natl Med Assoc 97[Suppl 7]:44S–51SPubMed Pearlman DN, Averbach AR, Zierler S, Cranston K (2005) Disparities in prenatal HIV testing: evidence for improving implementation of CDC screening guidelines. J Natl Med Assoc 97[Suppl 7]:44S–51SPubMed
21.
Zurück zum Zitat Sharland M, Blanche S, Castelli G, Ramos J, Gibb DM, PENTA Steering Committee (2004) PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med 5:61–86PubMedCrossRef Sharland M, Blanche S, Castelli G, Ramos J, Gibb DM, PENTA Steering Committee (2004) PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med 5:61–86PubMedCrossRef
23.
Zurück zum Zitat Wortley PM, Lindegren ML, Fleming PL (2001) Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation. MMWR Morb Mort Wkly Rep 11,50(RR-6):17–28 Wortley PM, Lindegren ML, Fleming PL (2001) Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation. MMWR Morb Mort Wkly Rep 11,50(RR-6):17–28
Metadaten
Titel
Characteristics of HIV-infected children recently diagnosed in Paris, France
verfasst von
Eugenia Macassa
Marianne Burgard
Florence Veber
Capucine Picard
Bénédicte Neven
Nizar Malhaoui
Christine Rouzioux
Stéphane Blanche
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 10/2006
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-006-0091-6

Weitere Artikel der Ausgabe 10/2006

European Journal of Pediatrics 10/2006 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.